EP Patent

EP0534756A2 — N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy)propylamines as norepinephrine uptake inhibiteurs

Assigned to Eli Lilly and Co · Expires 1993-03-31 · 33y expired

What this patent protects

This invention provides N-alkyl-3-phenyl-3-(2-substituted phenoxy)propylamines which are useful to treat neurological disorders associated with norepinephrine imbalance.

USPTO Abstract

This invention provides N-alkyl-3-phenyl-3-(2-substituted phenoxy)propylamines which are useful to treat neurological disorders associated with norepinephrine imbalance.

Drugs covered by this patent

Patent Metadata

Patent number
EP0534756A2
Jurisdiction
EP
Classification
—
Expires
1993-03-31
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.